134 related articles for article (PubMed ID: 26141623)
1. Evaluation of recombinant leukocidin domain of VvhA exotoxin of Vibrio vulnificus as an effective toxoid in mouse model.
Lohith GK; Kingston JJ; Singh AK; Murali HS; Batra HV
Immunol Lett; 2015 Sep; 167(1):47-53. PubMed ID: 26141623
[TBL] [Abstract][Full Text] [Related]
2. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
[TBL] [Abstract][Full Text] [Related]
3. A recombinant metalloprotease antigen of Vibrio vulnificus elicits protective antibodies in a murine model.
Chen YC; Chang CC; Chang SY; Su JH
Lett Appl Microbiol; 2010 Feb; 50(2):168-72. PubMed ID: 20002577
[TBL] [Abstract][Full Text] [Related]
4. Safety and vaccine efficacy of an attenuated Vibrio vulnificus strain with deletions in major cytotoxin genes.
Kim YR; Lee SE; Kim JR; Rhee JH
FEMS Microbiol Lett; 2015 Dec; 362(23):fnv169. PubMed ID: 26381905
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and characterization of monoclonal antibody against Vibrio vulnificus].
Fu KF; Ma C; Guo JW; Qiao YY; Hao XH; Wang DP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):279-81. PubMed ID: 22394637
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine.
Shoemaker CA; Lafrentz BR; Klesius PH
Biologicals; 2011 Nov; 39(6):424-9. PubMed ID: 21982852
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of Vibrio vulnificus flagellin protein FlaB in a wound infection model.
Yamazaki K; Kashimoto T; Hashimoto Y; Kado T; Ueno S
J Vet Med Sci; 2018 Jan; 80(1):55-58. PubMed ID: 29142160
[TBL] [Abstract][Full Text] [Related]
8. Outer membrane vesicles of Vibrio vulnificus deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity.
Kim YR; Kim BU; Kim SY; Kim CM; Na HS; Koh JT; Choy HE; Rhee JH; Lee SE
Biochem Biophys Res Commun; 2010 Sep; 399(4):607-12. PubMed ID: 20682286
[TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo efficacy of hen IgY against Vibrio parahaemolyticus and Vibrio vulnificus.
Kassim N; Mtenga AB; Shim WB; Chung DH
J Microbiol Biotechnol; 2012 Oct; 22(10):1423-31. PubMed ID: 23075795
[TBL] [Abstract][Full Text] [Related]
10. Production of Vibrio vulnificus hemolysin in vivo and its pathogenic significance.
Lee SE; Ryu PY; Kim SY; Kim YR; Koh JT; Kim OJ; Chung SS; Choy HE; Rhee JH
Biochem Biophys Res Commun; 2004 Nov; 324(1):86-91. PubMed ID: 15464986
[TBL] [Abstract][Full Text] [Related]
11.
Yuan Y; Feng Z; Wang J
Front Immunol; 2020; 11():599439. PubMed ID: 33193453
[TBL] [Abstract][Full Text] [Related]
12. Immunization with major outer membrane protein of Vibrio vulnificus elicits protective antibodies in a murine model.
Jung CR; Park MJ; Heo MS
J Microbiol; 2005 Oct; 43(5):437-42. PubMed ID: 16273036
[TBL] [Abstract][Full Text] [Related]
13. Swarming differentiation of vibrio vulnificus downregulates the expression of the vvhBA hemolysin gene via the LuxS quorum-sensing system.
Kim MY; Park RY; Choi MH; Sun HY; Kim CM; Kim SY; Rhee JH; Shin SH
J Microbiol; 2006 Apr; 44(2):226-32. PubMed ID: 16728960
[TBL] [Abstract][Full Text] [Related]
14. Suppression and inactivation of Vibrio vulnificus hemolysin in cirrhotic ascites, a human ex vivo experimental system.
Choi MH; Park RY; Sun HY; Kim CM; Bai YH; Lee SE; Kim SY; Kim YR; Rhee JH; Shin SH
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):226-32. PubMed ID: 16831209
[TBL] [Abstract][Full Text] [Related]
15. Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein.
Lee TH; Kim MH; Lee CS; Lee JH; Rhee JH; Chung KM
Vaccine; 2014 Jan; 32(2):271-6. PubMed ID: 24252692
[TBL] [Abstract][Full Text] [Related]
16. IL-21 Enhances the Immune Protection Induced by the Vibrio vulnificus Hemolysin A Protein.
Sun KN; Huang F; Wang MY; Wu J; Hu CJ; Liu XF
Inflammation; 2022 Aug; 45(4):1496-1506. PubMed ID: 35129769
[TBL] [Abstract][Full Text] [Related]
17. Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice.
Pan CY; Lee SC; Rajanbabu V; Lin CH; Chen JY
Dev Comp Immunol; 2012 Jan; 36(1):166-73. PubMed ID: 21756935
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a catalytically inactive cysteine protease domain of RtxA1/MARTXVv as a potential vaccine for Vibrio vulnificus.
Lee TH; Chung KM
Microbiol Immunol; 2015 Sep; 59(9):555-61. PubMed ID: 26177798
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
20.
Guo RH; Lim JY; Tra My DN; Jo SJ; Park JU; Rhee JH; Kim YR
Front Cell Infect Microbiol; 2018; 8():70. PubMed ID: 29600196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
